CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its comprehensive Extrahepatic RNA Delivery services. This new platform features multi-organ Lipid Nanoparticle (LNP) solutions and can be applied to ...Learn More

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is proud to announce the launch of its new line of Alkali-Tolerant AAV Affinity Agarose Resins. Specifically engineered for the biopharmaceutical industry, these high-capacity resins are ideal ...Learn More

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its product portfolio with a comprehensive range of Additive Powders, to meet the rigorous demands of researchers and industrial manufacturers in additive ...Learn More

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development of innovative and tailor-made vaccines for veterinary applications. This new ...Learn More

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a ...Learn More